6 Stocks Warren Buffett Just Bought

Warren Buffett is known for being a successful investor, and many people often wonder what stocks he is buying. He has purchased stakes in companies like Coca-Cola and American Express in the past. More recently, he has been investing in airlines and tech companies.

Some of Warren Buffett’s stocks recently bought include Apple, IBM, and Bank of America. He has also made smaller investments in companies like Mastercard and Visa. These stocks are all excellent choices for long-term investors, and they should do well in the years to come—holdings to the U.S. Securities and Exchange Commission every quarter via Form 13-F.

As a result, retail investors get to see behind the curtain some of the most significant and most successful hedge funds and money managers in the world. Berkshire Hathaway (ticker: BRK.A, BRK.B) CEO Warren Buffett may be the most popular and successful investor.

Buffett’s massive multinational conglomerate, which owns a wide range of subsidiaries that includes Dairy Queen, Duracell, Heinz, and Precision Castparts, earned an astounding $81.4 billion in net income in 2019

Here Are 6 Stocks Warren Buffett Just Bought

6. Pfizer (PFE)

Pfizer and partner BioNTech recently applied for emergency approval for the vaccine in the U.S., and it could be widely available sometime in 2021.

Warren Buffett is known as a shrewd investor, and when he buys stocks, people notice. Recently, Buffet’s company Berkshire Hathaway has been buying up shares of pharmaceutical giant Pfizer. While the reasons for this investment are not yet clear, many believe that Buffet sees good potential in the stock.

Pfizer is a major player in the pharmaceutical industry, and its stock has seen steady growth in recent years. The company has a strong product line-up and a solid financial position. It also pays a healthy dividend, making it an attractive investment for stability and income.

There is no doubt that Pfizer is a well-run company with a bright future. However, like all stocks, it is not without risk. Any downturn in the pharmaceutical industry could hurt Pfizer’s share price.

Market Cap: $206.9 Billion
Industry: Pharma

5. T-Mobile US (TMUS)

Warren Buffett has been a big fan of companies that offer cellphone service, and now he’s a big investor in T-Mobile US. Berkshire Hathaway Inc. has disclosed it has acquired 9.8 percent of the company, becoming its largest shareholder.

5G network T-Mobile is the third-largest wireless carrier in the U.S., with about 72 million customers. The company has been growing rapidly, adding more than 1 million customers each month for the last four quarters.

The purchase makes sense for Buffett because T-Mobile is expanding rapidly and offers a good value for consumers, said Jeff Matthews, author of “Pilgrimage to Warren Buffett’s Omaha.” The stock is also cheap compared to its peers.

Market Cap: $163.7 Billion
Industry: Telecom

4. Snowflake (SNOW)

Warren Buffett Berkshire portfolio manager is known as one of the greatest investors in the world. He is considered to be the “Oracle of Omaha.” In December, he made a move that surprised many people- he bought stocks in two companies that make snowflake-shaped decorations.

Why would Buffett invest in a company that makes holiday decorations? First, he may see a strong future for the industry. The demand for seasonal decor has been increasing as more and more people want to add a touch of winter to their homes.

Both of the companies that Buffett invested in are well-positioned to capitalize on this trend. They have strong brands and offer high-quality products. They’re also expanding their reach into new markets, which should help them grow even more in the years ahead.

Market Cap: $90.9 Billion
Industry: Cloud Data Platform

3. Bristol-Myers Squibb Co. (BMY)

Bristol-Myers Squibb Co. (NYSE: BMY) stocks are up this morning after Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.A) revealed it had purchased a stake in the pharmaceutical company. In a regulatory filing, Berkshire said it had bought nearly 10 million shares of Bristol-Myers, worth more than $1 billion as of Tuesday’s close.

The investment is another sign that Buffett is bullish on the stock market, despite concerns about a potential slowdown in the U.S. economy. It also underscores his faith in the drug industry, battered by pricing pressures and competition from generic drugs.

Bristol-Myers Squibb Co. (NYSE: BMY) is up 1% in premarket trading Wednesday after Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.)

Market Cap: $142.4 Billion
Industry: Pharma

2. Merck & Co. (MRK)

According to a recent SEC filing, Warren Buffett’s Berkshire Hathaway increased its stake in Merck & Co. by 3.9%. This brings the conglomerate’s total ownership in the pharmaceutical giant to nearly 49 million shares, worth over $2.1 billion at current prices. Buffett has been a long-term investor in Merck, and this latest move suggests he remains bullish on the stock even as drug prices come under scrutiny from lawmakers and the public.

Merck is one of Berkshire’s most significant holdings, and it has been a steady performer over the years. The company has an extensive product portfolio with prescription drugs and consumer health product offerings. It also has a robust R&D pipeline, which should help support growth.

While there are some concerns about drug pricing, Merck still appears to be a strong investment option for long-term investors.

Market Cap: $193.0 Million
Industry: Pharma

1. AbbVie (ABBV)

Warren Buffett is a big fan of AbbVie. So much so that he decided to invest billions of dollars into the company. In early 2019, Buffett’s investment firm Berkshire Hathaway purchased nearly 71 million shares of AbbVie stock. The total value of the investment was around $4.5 billion.

This move is interesting because it’s not often that Buffett invests in a pharmaceutical company. In the past, he has said that these types of businesses are too risky and unpredictable. So why did he decide to invest in AbbVie? It could be because the company is doing well financially and has a bright future.

Market Cap: $185.1 Billion
Industry: Pharma

Source: Yahoo Finance | Money/US News